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Abstract
Background Recent studies suggest that environmental
exposures to pesticides, tobacco, and other xenobiotic
chemicals may increase risk of childhood acute lympho-
blastic leukemia (ALL). We sought to evaluate the role of
genes involved in xenobiotic transport and metabolism in
childhood ALL risk, both alone and in conjunction with
household chemical exposures previously found to be
associated with childhood ALL risk.
Methods We conducted a population-based epidemiol-
ogic study of 377 cases and 448 controls in California,
utilizing a haplotype-based approach to evaluate 42 xeno-
biotic transport and metabolism genes in conjunction with
data on self-reported household chemical exposures.
Results We identified significant associations of child-
hood ALL risk with haplotypes of ABCB1, ARNT, CYP
2C8, CYP1A2, CYP1B1, and IDH1. In addition, certain
haplotypes showed significant joint effects with self-
reported household chemical exposures on risk of child-
hood ALL. Specifically, elevated risks associated with use
of paints in the home (ever) and indoor insecticides (pre-
birth) were limited to subjects carrying specific haplotypes
of CYP2C8 and ABCB1, respectively.
Conclusions Our results provide support for a role of
xenobiotic transport and metabolism pathways in risk of
childhood ALL and indicate that genes in these pathways
may modulate the risk of disease associated with use of
common household chemicals. Additional studies are
needed to confirm these findings and localize specific
causal variants.
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Introduction
Leukemia is the most common cancer among children
under 15 years of age, accounting for 32 % of all child-
hood malignancies [1]. In California, Hispanics have the
highest reported annual age-adjusted childhood leukemia
incidence (56.2 per million), followed by non-Hispanic
whites, Asian/Pacific Islanders, and non-Hispanic blacks
(44.6, 40.0, and 29.1 per million, respectively) [2]. Although
acute lymphoblastic leukemia (ALL) is the most common
subtype of childhood leukemia, comprising*80 % of total
disease [1], it is much rarer than most cancers in adults and
consequently more difficult to study epidemiologically. The
etiology of ALL in children is believed to be distinct from
that in adults, due largely to the clearer role for early life
exposures. However, few risk factors have been conclu-
sively established, including ionizing radiation, chemo-
therapeutic agents, and specific genetic abnormalities [3].
Recent studies from our group and others have found
elevated childhood ALL risks associated with self-reported
use of pesticides at home [4], household paint exposure [5],
paternal smoking before conception [6, 7], and surrogate
measures of exposure to motor vehicle exhaust [8–11]. In
order to exert their effects, these potentially harmful
xenobiotic (exogenous) chemicals must first gain entry into
target cells and undergo cellular metabolic processes that
alter their activity. Membrane transporters such as those
encoded by the multiple drug resistance (ABCB1/MDR1)
gene act as efflux pumps to expel compounds from the cell
and are strategically expressed in regions of the body that
act as epithelial barriers or perform excretory functions
[12]. In addition, enzymes involved in phase I (bioactiva-
tion) and phase II (detoxification) metabolism maintain a
critical balance of activation and inactivation of a wide
range of chemical exposures of relevance to childhood
ALL, including drugs, chemical carcinogens, insecticides,
petroleum products, nitrosamines, polycyclic aromatic
hydrocarbons, and other environmental pollutants [13].
In order to shed light on the role of genes involved in
xenobiotic transport and metabolism, both alone and in
conjunction with household chemical exposures, in child-
hood ALL risk, we utilized a haplotype-tagging approach
to characterize genetic variation in a population-based
study of 377 ALL case children and 448 control children in
Northern and Central California. Furthermore, we exam-
ined whether effects of exposure to common household
chemicals (including paints, solvents, pesticides, herbicides
and tobacco smoke) previously linked to risk of childhood




The study was conducted among children participating in
the Northern California Childhood Leukemia Study
(NCCLS), an ongoing population-based case–control study
conducted since 1995. The current study includes only
those subjects for whom genotyping data were available.
Enrollment and recruitment procedures have been descri-
bed in detail previously [14]. Briefly, case children with
incident childhood leukemia were ascertained via a rapid
reporting system between the study office and participating
hospitals. Control children identified from the state birth
certificate records were individually matched to case chil-
dren on date of birth, sex, maternal race, and child’s His-
panic ethnicity (having one or more parents reporting
Hispanic ethnicity). Participation rates among eligible
cases and controls were 87 and 86 %, respectively. Data on
various potential risk factors were elicited from a parent
(usually the mother) by trained interviewers using a
structured questionnaire.
This study was reviewed and approved by institutional
review committees at the University of California Berke-
ley, the California Department of Public Health (CDPH),
and the participating hospitals. Written informed consent
was obtained from all parent respondents.
DNA specimens
Buccal cytobrushes collected from 95 % of participating
children (cases and controls) enrolled between 1995 and
2002 were processed within 48 h of collection by heating
in the presence of 0.5 N NaOH. Isolated DNA was later
re-purified using an automated DNA extraction system
(AutoGen, Holliston, MA) and then whole-genome ampli
fied using GenomePlex reagents (Rubicon Genomics, Ann
Arbor, MI). When buccal cytobrush DNA was inadequate
(26.6 % of subjects), DNA was isolated from dried blood
spot specimens (DBSs) collected at birth and archived by
the Genetic Disease Screening Program of the CDPH. DBS
specimens were available for 91 % of California-born
participants (100 % of controls and 90 % of cases). After
extraction (QIAamp 96 DNA Blood Kit, QIAGEN, Ger-
many), these DNA samples were whole-genome amplified
using REPLI-g reagents (QIAGEN). All DNA samples
were quantitated using human-specific Alu-PCR to confirm
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a minimum level of amplifiable human DNA [15]. When
analyzed using highly multiplexed GoldenGate genotyping
(Illumina, San Diego, CA), whole-genome-amplified buc-
cal cell DNA yields genotypes that are highly concordant
with those from genomic DNA from peripheral blood [16].
We genotyped DNA specimens from both buccal cells and
DBS for 9 subjects; genotype concordance between paired
samples was 98.9 %.
Genotyping
Based on consensus review following review of the literature by
our investigative team, we selected 42 genes coding xenobiotic
transport and metabolism enzymes. Using HaploView software
[17] in conjunction with reference single nucleotide polymor-
phism (SNP) data from the 30 Caucasian trios in the HapMap
project (Release 19, Build 34, http://www.hapmap.org) and the
23 Hispanics in the SNP500Cancer project (http://www.snp
500cancer.nci.nih.gov), we applied the method of Gabriel et al.
[18] to select haplotype-tagging SNPs (htSNPs) that captured at
least 80 % of diversity for common haplotypes ([5 % fre-
quency) in either reference group. As Hispanics are a recently
admixed ethnic group, and 42 % of our study population is
Hispanic (at least one parent reporting Hispanic ethnicity), we
placed special emphasis on capturing haplotype structures in
Hispanics. To maximize capture of potential regulatory
regions, we included in the SNP selection 10-kb stretches both
up- and down-stream from the gene boundaries reported in the
UCSC Genome Browser.
Genotyping of the selected SNPs was attempted in 385
ALL cases and 456 controls using a custom Illumina
GoldenGate panel. We applied an Illumina GenCall quality
threshold of 0.25, and SNP-wise and subject-wise call rate
thresholds of C90 and C95 %, respectively. Genotypes for
duplicate DNA specimens from 59 subjects showed 99.1 %
concordance. Genotyped SNPs with an observed minor
allele frequency \5 % (n = 13), or showing significant
deviation from Hardy–Weinberg equilibrium (p \ 0.01,
n = 2), in both Hispanic controls and non-Hispanic con-
trols were excluded. After applying these data quality
thresholds, data for 250 SNPs in the 42 selected genes
(Supplementary Table A) were available for 377 ALL
cases and 448 controls.
In addition, we determined deletion status for GSTM1
and GSTT1 using polymerase chain reaction methods
described previously [19].
Household chemical exposure assessment
Details of data collection for self-reported household
chemical use in early childhood have been published
elsewhere [5, 20, 21]. Briefly, utilizing an in-home inter-
view with a structured questionnaire, we asked parents
whether paints, stains, or lacquers (collectively called
‘‘paints’’); adhesives or petroleum products, such as paint
thinner, spot remover, paint remover, glue, solvent, gaso-
line, kerosene, or lubricating oil (collectively called ‘‘sol-
vents’’); professional lawn service and the use of weed
control products (collectively called ‘‘outdoor herbicides’’);
or professional pest control services, insect repellents, flea
foggers, and products to control ants, flies, cockroaches,
spiders, termites, and plant/tree insects (collectively called
‘‘indoor insecticides’’); were ever used in the home during
specific time windows from the 3 months prior to preg-
nancy through either the child’s 3rd birthday or diagnosis
age (reference age among controls). For this analysis, we
focused on time windows for which the chemicals showed
significant main effects in our previous analyses [5, 20, 21].
Accordingly, for paints and solvents, we censored expo-
sures at the time window preceding the reference date (e.g.,
from birth to 1 year if the case was diagnosed between 1
and 2 years of age). For outdoor herbicides and indoor
insecticides, we limited to exposures before birth. We also
ascertained whether there were any tobacco smokers in the
house from birth through the child’s 3rd birthday. For the
purpose of this analysis, all exposures were classified as
‘‘ever/never’’ during the specified time window. The sub-
jects in the current study comprise a subset of subjects in
our previous reports linking household chemicals to
childhood leukemia risk. In the current study subset, we
found the observed associations of these household
chemicals with risk of childhood ALL were consistent with
our previous reports: paint use (OR = 1.42, 95 % CI:
1.06–1.92), outdoor herbicides before birth (OR = 1.46,
95 % CI: 1.04–2.04), and indoor insecticides before birth
(OR = 1.29, 95 % CI: 0.97–1.72). We previously found
solvents to be associated with childhood acute myeloid
leukemia, and household passive tobacco exposure after
birth showed joint effects with paternal smoking on
childhood ALL risk. We found no main effects of these two
exposures in our study sample.
Statistical analysis
Using a set of 80 ancestry informative markers [22], we
have previously calculated individual estimates of Amer-
indian, African, and European genetic ancestry [23] using
structured association methods [24, 25]. We found no
evidence of major confounding by estimated genetic
ancestry ([10 %) over and above adjustment for self-
reported race and ethnicity [23]. Thus, we used stratifica-
tion or adjustment for the self-reported factors in our
analyses.
As a preliminary step prior to haplotype analysis, we
tested for potential interactions of individual htSNPs with
Cancer Causes Control (2012) 23:1367–1375 1369
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Hispanic ethnicity in disease risk on a gene-by-gene basis
using unconditional logistic regression and the likelihood
ratio test at the 0.05 significance level, after adjusting for
age, sex, and child’s race.
For haplotype analysis, we used a haplotype sliding
window approach for the SNPs in each gene, as implemented
in the haplo.stats package for R [26]. This approach exam-
ines sub-haplotypes using the full set of SNP data, with
differently sized ‘‘windows’’ of adjacent alleles. This is an
effective means of combining multi-locus data for Hispanics
and non-Hispanics alike, as it is agnostic to differences in
haplotype structure, provided no individual SNPs for a given
gene have a strong differential effect by Hispanic ethnicity.
Thus, if none of the SNPs in a given gene showed significant
interaction with ethnicity at p B 0.05, data for both ethnic-
ities were combined for haplotype analyses; otherwise, the
haplotype analysis for that gene was conducted separately
for Hispanics and non-Hispanics. We utilized GrASP, a
graphical tool [27] to display and visualize sliding window
results (Supplementary Figure 1). Using haplotype trend
regression [28], we estimated the magnitude of effect asso-
ciated with risk haplotypes from the windows with the
smallest global p values, collapsing haplotypes with\5 %
frequency among controls into a ‘‘rare haplotypes’’ category.
We tested the significance of potential interactions between
self-reported household chemical exposures and risk hap-
lotypes using the likelihood ratio test, focusing on haplotypes
with significant main effects among all subjects (i.e., both
Hispanics and non-Hispanics combined) in order to maxi-
mize statistical power to detect interaction effects. We report
both nominal and false discovery rate (FDR)-adjusted
p values for the interaction analysis, adjusted for the total
number of interactions examined [29]. Lastly, for haplotype-
chemical interactions significant at pFDR B 0.05, we derived
effect estimates for household chemicals by haplotype sta-
tus, applying to each subject the haplotypes with the highest
inferred probability.
Results
Due to the matched case–control design of the NCCLS, the
distribution of age, gender, race, and ethnicity was com-
parable between the 377 ALL cases and the 448 controls
(Table 1). The 42 xenobiotic transport and metabolism
pathway genes we examined are listed in Supplementary
Table A. We found that htSNPs in eight genes (ABCC1,
CYP1A2, CYP1B1, CYP2B6, CYP3A5, GSS, IDH1, and
UGT1A9) showed significant heterogeneity of effect
between Hispanics and non-Hispanics (p B 0.05); further
analyses for these genes were stratified by ethnicity.
Results for genes with significant (p B 0.05) haplotype
effects that persisted through increasingly larger windows
are presented in Supplementary Figure 1. Haplotype trend
regression results estimating the magnitudes of effect for
haplotypes with the lowest multi-SNP p-value in sliding
window analyses are shown in Table 2.
Among all subjects, ABCB1, ARNT, CYP2C8, and GCLC
showed significant associations that persisted through pro-
gressively larger SNP windows (Table 2). In ABCB1, hap-
lotype G–A–G–T was associated with a significantly
reduced risk (OR = 0.44, p = 0.015). Haplotypes G–G of
ARNT and G–G–T–G of CYP2C8 were significantly asso-
ciated with increased risks of childhood ALL (OR = 4.93
and p = 0.001, OR = 3.18 and p = 0.004, respectively).
The observed significant global haplotype association of
GCLC was attributed to a rare haplotype; no further analysis
was performed for this gene.
Among non-Hispanics, CYP1A2 and CYP1B1 showed
significant haplotype associations. Haplotype A–G of
Table 1 Characteristics of childhood acute lymphoblastic leukemia
cases and controls, NCCLS
Variable Cases Controls
n (%) n (%)
Total 377 (100.0) 448 (100.0)
Sex
Male 200 (53.1) 237 (52.9)
Female 177 (46.9) 211 (47.1)
Age at diagnosis or reference date
Under 1 year 12 (3.2) 19 (4.2)
1–5 years 243 (64.5) 282 (62.9)
6–10 years 85 (22.5) 95 (21.2)
11–14 years 37 (9.8) 52 (11.6)
Child’s self-reported ethnicity
Non-Hispanic 221 (58.6) 269 (60.0)
Hispanic 156 (41.4) 179 (40.0)
Child’s self-reported race
White 214 (56.8) 255 (56.9)
Black 15 (4.0) 16 (3.6)
Native American 7 (1.9) 8 (1.8)
Asian/Pacific Islander 25 (6.6) 35 (7.8)
Mixed 110 (29.2) 133 (29.7)
Do not know 6 (1.6) 1 (0.2)
Mean percent (SE) Mean percent (SE)
Genetic ancestrya
African 7.3 (14.7) 7.1 (14.5)
Amerindian 24.2 (23.7) 22.2 (22.8)
European 68.5 (27.3) 70.7 (26.9)
a Individual percent genetic ancestry estimated using 80 ancestry
informative markers (AIMs) as described in Aldrich et al. Presented
data are means of individual estimated percentages (and standard
errors) of each ancestral population among cases and controls
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CYP1A2 was significantly associated with an increased risk
(OR = 2.19, p = 0.005), while haplotype A–A of CYP1B1
was significantly associated with a decreased risk (OR =
0.11, p = 0.007). The observed significant global haplo-
type association of CYP2B6 was attributed to rare haplo-
types. Among Hispanics, the two SNPs in IDH1 showed a
haplotype association stronger than either SNP individually
(global p = 0.008), and the C–C haplotype was signifi-
cantly associated with an increased risk of ALL (OR =
6.12, p = 0.005).
Two of the most commonly studied xenobiotic metab-
olism genes to date in childhood ALL are the glutathione S
transferase genes GSTM1 and GSTT1, whose principal
variants are deletions [30]. The GSTM1 deletion showed













All Rare haplotypes 0.022 0.016 0.42 (0.08, 2.09) 0.289 0.019
G–A–A–T 0.080 0.107 1.66 (0.83, 3.32) 0.153
G–A–G–T 0.136 0.096 0.44 (0.23, 0.85) 0.015
G–A–A–A 0.142 0.165 1.25 (0.70, 2.24) 0.454
G–G–G–T 0.168 0.144 0.68 (0.39, 1.20) 0.185
A–A–A–T 0.452 0.472 Ref
ARNT rs2228099,
rs4379678
All Rare haplotypes \0.001 \0.001 – 0.011 0.003
G–G 0.064 0.101 4.93 (1.94, 12.53) 0.001
C–A 0.410 0.389 1.09 (0.72, 1.66) 0.675





All Rare haplotypes 0.026 0.026 1.29 (0.36, 4.62) 0.699 0.046
G–G–T–G 0.059 0.092 3.18 (1.45, 6.95) 0.004
A–G–T–A 0.239 0.260 1.57 (0.96, 2.56) 0.071
A–A–T–A 0.258 0.261 1.34 (0.83, 2.15) 0.232
A–A–A–A 0.417 0.361 Ref
GCLC rs553822,
rs3799696
All Rare haplotypes 0.015 0.032 17.47 (2.63, 116.1) 0.003 0.012
A–G 0.297 0.287 1.23 (0.75, 2.02) 0.408
G–G 0.327 0.349 1.42 (0.89, 2.27) 0.145
A–A 0.361 0.332 Ref
CYP1A2 rs11854147,
rs11072508
NH Rare haplotypes 0.046 0.022 0.14 (0.03, 0.76) 0.022 0.001
G–G 0.117 0.081 0.49 (0.20, 1.19) 0.116
A–G 0.315 0.414 2.19 (1.28, 3.77) 0.005
G–A 0.522 0.483 Ref
CYP1B1 rs162557,
rs162556
NH A–A 0.081 0.040 0.11 (0.02, 0.56) 0.007 0.007
A–G 0.140 0.160 1.71 (0.80, 3.68) 0.169
G–G 0.301 0.339 1.18 (0.62, 2.24) 0.612





NH Rare haplotypes 0.009 0.028 16.92 (1.54, 186.3) 0.021 0.037
G–A–G–C 0.086 0.094 1.18 (0.48, 2.94) 0.719
A–G–A–A 0.207 0.245 1.53 (0.81, 2.90) 0.193
A–A–G–C 0.256 0.211 0.70 (0.36, 1.36) 0.292
A–A–A–C 0.442 0.423 Ref
IDH1 rs1992739,
rs4290589
Hisp C–G 0.054 0.048 0.55 (0.11, 2.81) 0.474 0.008
C–C 0.058 0.127 6.12 (1.75, 21.36) 0.005
G–G 0.144 0.103 0.61 (0.22, 1.73) 0.355
G–C 0.743 0.722 Ref
a NH non-Hispanics, Hisp Hispanics, All non-Hispanics and Hispanics combined
b ‘‘Rare haplotypes’’ refers to combined group of individual haplotypes with \5 % frequency among controls
c 377 childhood ALL cases, 448 controls
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significantly different effects by Hispanic ethnicity
(p \ 0.001): among Hispanics the deletion was associated
with elevated risk (OR = 1.85, 95 % CI 1.19–2.88, p =
0.007) while among non-Hispanics, the association was in
the opposite direction (OR = 0.62, 95 % CI 0.43–0.89,
p = 0.010). In addition, there was no evidence of associ-
ation for the GSTT1 deletion (p = 0.526).
Finally, we examined interactions between household
chemical exposures of interest and xenobiotic gene variants.
For this analysis, we focused on haplotypes with at least 5 %
frequency among controls and showed nominally significant
main effects (global p B 0.05) among Hispanics and non-
Hispanics combined. We found significant interactions
between CYP2C8 haplotype G–G–T–G and self-reported
use of paints after birth (pFDR = 0.016), and ABCB1 hap-
lotype G–A–G–T and self-reported use of indoor insecti-
cides before birth (pFDR = 0.035) (Table 3). As shown in
Table 4, our analysis indicates that the risks of childhood
ALL associated with use of paints and indoor insecticides
vary by presence or absence of these haplotypes. The
increased risks associated with paint use appears confined to
those with CYP2C8 haplotype G–G–T–G (OR = 1.67,
95 % CI 1.21–2.30), while in the small subgroup without the
G–G–T–G haplotype (5.9 % among controls), paint use
appears to be associated with a non-significant reduced risk
(OR = 0.45, 95 % CI = 0.20–1.02). Similarly, the increased
risk associated with use of indoor insecticides appears to be
limited to the small population with the ABCB1 G–A–G–T
haplotype (13.6 % among controls, OR for indoor insecti-
cides = 3.03, 95 % CI = 1.59–5.78), while among those
without the G–A–G–T haplotype, the risk associated with
indoor insecticide use was null (OR = 1.02, 95 %
CI = 0.74–1.41).
Discussion
In this population-based case–control study, we examined
the risk of childhood ALL associated with several genes
within the xenobiotic transport and metabolism pathways,
utilizing a haplotype-tagging approach to maximize cap-
ture of genetic variation. We identified haplotypes of
several genes that were significantly associated with child-
hood ALL, including ABCB1, ARNT, CYP2C8, CYP1A2,
CYP1B1, and IDH1. In addition, we observed significant
interactions of identified risk haplotypes with a number of
self-reported household chemical exposures, including use
of paints and indoor insecticides. Although confirmation is
required, our findings provide evidence that genes involved
in the xenobiotic transport and metabolism pathway may
play a role in mediating risk of childhood ALL, and that the
childhood ALL risks associated with various household
chemical exposures may be modified by these variation in
these genes.
A haplotype of ABCB1, which encodes a membrane
transporter of lipophilic compounds, was significantly
associated with childhood ALL risk and showed significant
interaction with indoor insecticides, mirroring an earlier
finding utilizing different genetic variants in the same gene
[31]. Our results indicate that the increased risk associated
with use of indoor insecticides before birth is limited to
subjects carrying the G–A–G–T haplotype. The SNPs in
this risk haplotype are 21 kb from the nearest of the 30
SNPs examined in our previous analysis, in which no
significant haplotype main effect was observed [31]. This is
in agreement with the current analysis, which also shows
no main effect of haplotypes at the 30 end of the gene.
We also found significant childhood ALL associations
with haplotypes in three genes in the CYP gene family:
CYP2C8, CYP1A2, and CYP1B1. The CYP2C8 gene prod-
uct is involved in metabolism of numerous drugs and other
compounds [32]. In addition to a significant association
with childhood ALL, the risk haplotype for CYP2C8
showed significant interaction with self-reported household
paint use, with the increased risk associated with paint use
being limited largely to those without the CYP2C8 G–G–
T–G haplotype. For the common haplotype in CYP1A2
(31.5 % frequency among controls), we found an elevated
Table 3 Interactions of household chemical exposures with xenobiotic metabolism and transport genes on childhood acute lymphoblastic
leukemia risk a
Gene Haplotype Main effect
pNominal
Interaction with:














CYP2C8 Hap G–G–T–G 0.014 0.001 0.016 0.022 0.082 0.253 0.474 0.013 0.067 0.300 0.501
ABCB1 Hap G–A–G–T 0.013 0.850 0.931 0.587 0.834 0.869 0.931 0.005 0.035 0.612 0.834
ARNT Hap G–G 0.009 0.699 0.874 0.028 0.083 0.996 0.996 0.068 0.146 0.042 0.105
a Analyses conducted for haplotypes with significant main effects (global p B 0.05) among all ethnicities combined
b FDR adjusted for total number of interaction tests conducted (n = 15)
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risk of childhood ALL. The SNPs composing this haplo-
type are outside the CYP1A2 coding region, the nearest
(rs11854147) being 5.4 kb from the 30 end. The CYP1A2
gene product metabolizes polycyclic aromatic hydrocar-
bons (PAHs, found in tobacco smoke and vehicle exhaust);
in utero exposures to PAHs have been linked to chromo-
somal aberrations [33]. CYP1B1, for which we observed a
significant haplotype association with childhood ALL risk,
is also involved in metabolism of PAHs, as well as steroids
[34].
The ARNT gene product is a key transporter of PAHs and
other compounds, and a transcription inducer of xenobiotic
metabolism genes including CYP1A1 and CYP1A2 [35] that
metabolize PAHs. We identified a risk haplotype for ARNT
that showed a markedly higher risk of childhood ALL. We
also observed a strong haplotype association for IDH1; a
somatic mutation in IDH1 has been linked to survival in
adult glioblastoma and AML [36, 37]. The two SNPs we
examined are downstream from and in strong LD with SNPs
in the IDH1 coding region.
In gauging these results, consideration must be given to
several factors. First, despite this study’s relatively large
sample size compared to those of most previous candidate
gene studies, the presence of genetic heterogeneity due to
the ethnic and racial diversity of the California population
may have influenced our ability to detect associations. Our
SNP selection strategy included elements designed to
maximize capture of genetic variation in Hispanics. We
examined Hispanics separately from non-Hispanics where
there was significant heterogeneity in between-group
effects of individual SNPs. Although this approach may
have limited our ability to detect associations in the pop-
ulation as a whole, we believe it was necessary given that
genetic susceptibility may be different in Hispanics versus
non-Hispanics due to the Hispanic population’s relatively
recent genetic admixture [22]. Results that differ between
Hispanics and non-Hispanics may be due to differences in
allele frequency and/or haplotype structure or may reflect
underlying differences in exposures that modulate the
effects of genes. Regardless, if the results are not spurious,
they represent potential risk loci, and we present them in
either or both ethnic groups for replication and further
followup. Whereas the entire study population yielded
adequate power to detect modest effect sizes (81 % power
for ORlog additive = 1.40, minor allele frequency = 20 %),
power was lower among Hispanics and non-Hispanics
separately (44 and 59 %, respectively). In addition, the
limited size of racial/ethnic sub-populations within the
non-Hispanic group precluded further stratification of this
group; as such, genetic heterogeneity among non-Hispanics
might have obscured results. However, we found no evi-
dence of strong confounding due to estimated genetic
ancestry [23], minimizing concerns about the impact of
population stratification on the results.
Two large genome-wide association studies on child-
hood ALL have been published to date (with 907 cases and
2,398 adult and child controls, and 317 cases and 17,958
adult controls, respectively) [38, 39]. Although these
studies have identified a number of novel loci, no signifi-
cant associations were observed for genes in the pathways
we studied here. Null findings for these genes in the gen-
ome-wide studies may be due to stringent multiple testing
adjustment (at the p B 1 9 10-7 level) to account for the
large number of individual variants under study. In contrast
to the agnostic approach to discovery used in genome-wide
studies, our study focused on relatively few genes repre-
senting key elements of the xenobiotic transport and
metabolism pathways. We concede that results of our study
may be due to chance and therefore must be replicated.
However, the haplotype-tagging approach we adopted
maximizes capture of total variation within each candidate
gene and the haplotype analysis increases statistical power
to detect associations over analyses of individual variants.
Furthermore, although the haplotype-tagging approach
Table 4 Chemical by haplotype interaction analysis: effect sizes for childhood ALL risk
Haplotype Exposure n Cases n Controls Risk of childhood ALL
OR (95 % CI) Wald p
CYP2C8 G–G–T–G Paint in house, ever
N N 133 202 1.00 (ref)
N Y 178 195 1.67 (1.21–2.30) 0.0020
Y N 29 13 1.00 (ref)
Y Y 37 38 0.45 (0.20–1.02) 0.0571
ABCB1 G–A–G–T Indoor insecticide, pre-birth
N N 136 146 1.00 (ref)
N Y 174 186 1.02 (0.74–1.41) 0.8976
Y N 21 65 1.00 (ref)
Y Y 46 51 3.03 (1.59–5.78) 0.0008
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does not pinpoint potential causal SNPs, it does localize
risk-associated regions for further investigation such as
fine-mapping.
In this study, we examined potential interactions of
xenobiotic transport and metabolism genes with self-
reported household chemical exposures early in childhood
in the modulation of childhood ALL risk, focusing on
haplotype findings observed for both ethnicities (Hispanics
and non-Hispanics) combined, as the sizes of the individ-
ual ethnic groups were considered too small to permit
adequately powered examinations of gene–environment
interactions. Our observation that the increased risk asso-
ciated with paint and indoor insecticide use [5, 20] was
limited to specific subgroups defined by haplotypes of
specific genes is suggestive that these genes work in con-
cert with chemical use to modulate risk. Although we
focused on a limited number of biologically plausible
interactions according to a rigorous a priori analysis plan,
we acknowledge that this analysis might be considered
exploratory. As such we report only those interactions that
were significant after accounting for multiple hypothesis
testing. We recognize that our total sample size (377 cases,
448 controls) may be insufficient to observe modest
interaction effects with adequate statistical power. Fur-
thermore, although the environmental chemical exposures
we examined have been previously associated with child-
hood leukemia risk [5, 21], these measures are derived
from maternal self-reports, which are prone to reporting
errors and recall bias in that mothers of cases may recall
exposures differently than mothers of controls. Since this
study was population-based with participation rates of
86–87 % and biospecimen collection rates [95 % for
interviewed subjects, it is unlikely the results presented
here are driven by bias in selection or participation. Further
studies with improved measures of chemical exposure are
needed to confirm the interactions observed.
In summary, we set out to investigate the role of genes
in the xenobiotic transport and metabolism pathway in risk
of childhood ALL in greater depth and with larger sample
size than previous candidate gene studies. We also sought
to examine the putative joint effects of these genes with
environmental chemical exposures for which we have
observed significant main effects. Our results provide evi-
dence that elements of the xenobiotic transport and
metabolism pathway may be associated with childhood
ALL, and that some of these elements interact with
chemical exposures to modulate risk. This study does not
address the potential effects of maternal genes, which may
influence in utero susceptibility to chemical exposures. The
associations and interactions identified should be consid-
ered targets for further study in additional studies, with
larger sample sizes, high quality environmental exposure
data, maternal genes, and finer coverage of SNPs in the
identified associated regions.
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